Testing a tiny tablet of obefazimod in healthy adults
This study tests how a new form of the medicine obefazimod (a tiny tablet) is absorbed by the body, and whether people find it easy to take. It is for healthy adults ages 18–55 who are not taking other medications and are generally well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 55 years old
- Generally healthy (no serious health conditions or chronic infections)
- Not pregnant or breastfeeding, and willing to use birth control if needed
- Have a BMI between 18 and 32, and weigh at least 110 pounds (50 kg)
- No history of gallstones or gallbladder removal
- No smoking or nicotine use in the past 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.
This study tests a new tablet, HL40626S, in healthy volunteers to understand its safety and how the body processes it. If you are a healthy adult, you may be able to help researchers gather important information for future treatments.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.